Microcytic anemia is a condition where your red blood cells are smaller than normal and carry less hemoglobin, the protein responsible for delivering oxygen throughout your body. It’s defined by a mean corpuscular volume (MCV) below 80 femtoliters on a standard blood test. Iron deficiency is by far the most common cause, but several other conditions can produce the same small-cell pattern, and telling them apart matters because the treatments are completely different.
How Red Blood Cells Become Too Small
Red blood cells need iron to build hemoglobin. When the supply of iron is limited, the bone marrow produces cells that are smaller and paler than usual because each one contains less hemoglobin. This is the straightforward version: not enough iron coming in, too much going out, or both.
But iron can also be present in the body and still unavailable. During chronic infections or inflammatory conditions like rheumatoid arthritis or inflammatory bowel disease, the liver ramps up production of a hormone called hepcidin. Hepcidin blocks the main iron transporter on cells in the gut and in immune cells called macrophages, effectively locking iron away so it can’t reach the bone marrow. The result is anemia even when iron stores aren’t truly depleted. In genetic conditions like thalassemia, the problem is different again: the body has plenty of iron but can’t assemble hemoglobin chains correctly, producing small, fragile red blood cells.
The Most Common Causes
Iron deficiency accounts for the vast majority of microcytic anemia worldwide. In premenopausal women, heavy menstrual bleeding is the leading driver. In men and postmenopausal women, the cause is more often slow blood loss from the gastrointestinal tract, sometimes from ulcers, polyps, or colorectal cancer. Poor dietary intake, pregnancy, and conditions that impair iron absorption (like celiac disease or gastric bypass surgery) also contribute.
Thalassemia trait is the second most common cause. This is an inherited condition where one or more genes for hemoglobin production are altered. People with thalassemia trait often have very small red blood cells but only mild anemia, and they may go their entire lives without knowing they carry the trait unless it shows up on a routine blood count.
Less frequently, microcytic anemia results from chronic disease, lead exposure, or sideroblastic anemia, a rare condition where iron accumulates in ring-shaped deposits around the nucleus of developing red blood cells in the bone marrow instead of being incorporated into hemoglobin. In children, lead poisoning can cause microcytic anemia at blood lead levels around 25 to 40 micrograms per deciliter, though lower levels still cause harm.
Symptoms and Physical Signs
Mild microcytic anemia often causes no symptoms at all, especially when it develops slowly. Your body adapts to gradual drops in oxygen-carrying capacity, so you may not notice anything until the anemia becomes moderate or severe. When symptoms do appear, they typically include fatigue, shortness of breath during activity, dizziness, and a general sense of weakness.
Iron deficiency specifically produces some distinctive signs. About half of people with true iron deficiency develop pica, an unusual craving for non-food substances. Pagophagia, the compulsive craving for ice, is particularly characteristic. Other physical findings include dry skin, hair loss, cracking at the corners of the mouth, a smooth and sore tongue (from loss of the normal surface texture), and brittle nails that may eventually curve upward into a spoon shape, a finding called koilonychia. Pallor, particularly visible in the inner eyelids, tends to be a later sign that indicates more significant anemia.
How Doctors Tell the Causes Apart
A complete blood count is the starting point. Beyond confirming that red blood cells are small (MCV below 80 fL), two additional values help narrow the diagnosis. The red cell distribution width (RDW) measures how much variation there is in cell size. In iron deficiency, cells vary widely because the marrow produces progressively smaller cells as iron runs out, raising the RDW. In thalassemia trait, cells are uniformly small, so the RDW is more often normal, though this distinction isn’t perfectly reliable since nearly half of thalassemia cases also show an elevated RDW.
A simple calculation called the Mentzer index can help distinguish the two. It divides the MCV by the red blood cell count. A result above 13 points toward iron deficiency, while a value below 13 suggests thalassemia trait. This is a screening tool, not a definitive test, but it’s a useful first step.
Iron studies provide more clarity. A serum ferritin below 30 ng/mL confirms iron deficiency regardless of whether anemia is present. When ferritin results are ambiguous (ferritin can be falsely elevated by inflammation), a transferrin saturation below 20% adds further evidence that iron stores are low. Hemoglobin electrophoresis or genetic testing confirms thalassemia when suspected.
Treatment for Iron Deficiency
When iron deficiency is the cause, treatment focuses on replenishing iron stores and identifying the source of loss. Oral iron supplements are first-line therapy. Some guidelines recommend 150 to 200 mg of elemental iron daily split into multiple doses, but recent evidence suggests that 60 to 120 mg taken every other morning with a source of vitamin C may work just as well while causing fewer side effects like nausea, constipation, and stomach pain. The alternate-day approach improves absorption because high doses of iron trigger a temporary spike in hepcidin that blocks absorption for the next 24 hours.
You can expect to feel more energetic within a couple of weeks as new red blood cells enter circulation, but fully restoring iron reserves takes longer. Most people need to continue supplementation for three to six months after their hemoglobin normalizes. If oral iron doesn’t improve your numbers, or if you can’t tolerate it, intravenous iron is an effective alternative that bypasses the gut entirely.
Finding the underlying cause of iron loss is just as important as replacing the iron itself. In younger women, this often means addressing heavy periods. In older adults, it may require evaluation of the digestive tract to rule out a source of bleeding.
When the Cause Isn’t Iron Deficiency
Thalassemia trait generally doesn’t require treatment. People with the trait have mild anemia that stays stable over time, and iron supplements won’t help because iron isn’t the problem. Taking unnecessary iron can actually lead to iron overload, which damages the liver and heart. The main clinical significance of thalassemia trait is genetic: if both parents carry the trait, their children may inherit a more severe form of the disease.
Anemia of chronic disease improves when the underlying inflammatory condition is treated. Reducing inflammation lowers hepcidin levels and allows iron to flow normally again. Lead-related anemia resolves with removal of the lead source and, in severe cases, chelation therapy to clear lead from the body. Sideroblastic anemia is managed differently depending on whether it’s inherited or acquired, and some forms respond to high-dose vitamin B6.
The key takeaway across all types: a low MCV on a blood test is a signal, not a diagnosis. The number tells you red blood cells are small, but the cause determines what happens next, and treating the wrong cause can do more harm than good.